PE20080329A1 - TREATMENT OF CYST FIBROSIS WITH ANTIBIOTICS VIA A DRUG IN AEROSOL - Google Patents

TREATMENT OF CYST FIBROSIS WITH ANTIBIOTICS VIA A DRUG IN AEROSOL

Info

Publication number
PE20080329A1
PE20080329A1 PE2007000682A PE2007000682A PE20080329A1 PE 20080329 A1 PE20080329 A1 PE 20080329A1 PE 2007000682 A PE2007000682 A PE 2007000682A PE 2007000682 A PE2007000682 A PE 2007000682A PE 20080329 A1 PE20080329 A1 PE 20080329A1
Authority
PE
Peru
Prior art keywords
aerosol
treatment
drug
dextrose
inhalers
Prior art date
Application number
PE2007000682A
Other languages
Spanish (es)
Inventor
Hanumantharao Tatapudy
M Shah Syed
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PE20080329A1 publication Critical patent/PE20080329A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE CONTIENE UN ANTIBIOTICO SELECCIONADO DE ZOSYN, PIPERACILINA, TAZOBACTAM O TYGACIL; Y UN DILUYENTE SELECCIONADO DE AGUA ESTERIL PARA INYECTABLE, 0.9% DE CLORURO DE SODIO, 5% DE DEXTROSA, 5% DE DEXTROSA EN SOLUCION RINGER LACTADA PARA INYECCION. DICHA COMPOSICION ES UN AEROSOL, DONDE EL SUMINISTRO DE DROGA, CUYO TAMANO DE PARTICULA ES DE 1-3 MICRONES EN AEROSOL, COMPRENDE UN INHALADOR DE POLVO SECO EN DOSIS UNITARIA, UN DISPOSITIVO PULMONAR PARA POLVO SECO, INHALADORES PRESURIZADOS PARA DOSIS MEDIDAS O UN NEBULIZADOR, ENTRE OTRAS. DICHA COMPOSICION ES UTIL EN EL TRATAMIENTO DE TRASTORNOS RESPIRATORIOS PROVOCADOS POR LA FIBROSIS CISTICAREFERS TO A PHARMACEUTICAL COMPOSITION CONTAINING AN ANTIBIOTIC SELECTED FROM ZOSYN, PIPERACILIN, TAZOBACTAM OR TYGACIL; AND A SELECTED DILUENT OF STERILE WATER FOR INJECTABLE, 0.9% SODIUM CHLORIDE, 5% DEXTROSE, 5% DEXTROSE IN LACTED RINGER SOLUTION FOR INJECTION. SAID COMPOSITION IS AN AEROSOL, WHERE THE DRUG SUPPLY, WHOSE PARTICLE SIZE IS 1-3 MICRONS IN AEROSOL, INCLUDES A DRY POWDER INHALER IN UNIT DOSE, A PULMONARY DEVICE FOR DRY POWDER, INHALERS FOR MEDICATED DOSES INHALERS FOR PRESSURIZED DOSES , AMONG OTHER. SUCH COMPOSITION IS USEFUL IN THE TREATMENT OF RESPIRATORY DISORDERS CAUSED BY CYSTAL FIBROSIS

PE2007000682A 2006-06-07 2007-06-01 TREATMENT OF CYST FIBROSIS WITH ANTIBIOTICS VIA A DRUG IN AEROSOL PE20080329A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81167206P 2006-06-07 2006-06-07

Publications (1)

Publication Number Publication Date
PE20080329A1 true PE20080329A1 (en) 2008-04-09

Family

ID=38508902

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000682A PE20080329A1 (en) 2006-06-07 2007-06-01 TREATMENT OF CYST FIBROSIS WITH ANTIBIOTICS VIA A DRUG IN AEROSOL

Country Status (4)

Country Link
AR (1) AR061262A1 (en)
PE (1) PE20080329A1 (en)
TW (1) TW200815002A (en)
WO (1) WO2007145868A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102641249A (en) * 2012-05-06 2012-08-22 江苏奥赛康药业股份有限公司 Preparation method of tigecycline composition
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US20140274993A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane-tazobactam pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
UA121298C2 (en) 2013-03-15 2020-05-12 Мерк Шарп І Доум Корп. ANTIBIOTIC COMPOSITION BASED ON CEFTOLOSAN AND TAZOBACTAM
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
EP3976050A1 (en) * 2019-05-24 2022-04-06 Stichting Radboud universitair medisch centrum Improved administration of glycylcyclines by inhalation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
US5611332A (en) * 1995-03-22 1997-03-18 Bono; Michael Aerosol inhalation device containing a rain-off chamber
GB0004531D0 (en) * 2000-02-25 2000-04-19 Richards Andrew J M The treatment of respiratory diseases
US20030051728A1 (en) * 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
AU2003230600B2 (en) * 2002-03-05 2009-06-04 Transave, Inc. An inhalation system for prevention and treatment of intracellular infections

Also Published As

Publication number Publication date
AR061262A1 (en) 2008-08-13
WO2007145868A1 (en) 2007-12-21
TW200815002A (en) 2008-04-01

Similar Documents

Publication Publication Date Title
PE20080329A1 (en) TREATMENT OF CYST FIBROSIS WITH ANTIBIOTICS VIA A DRUG IN AEROSOL
AR111572A2 (en) PHARMACEUTICAL FORMS CONTAINING VARDENAFILO
ES2831177T3 (en) Aerosol generator
ES2644572T3 (en) An inhaler comprising a composition containing tiotropium
CL2007001018A1 (en) Inhaler for administering a medicament in the form of inhalable substances, formulations or mixtures of substances, it comprises a housing that has an interior to remove the medication, the housing is fixedly attached to a mouthpiece, in addition it can incorporate a needle to pierce a capsule with medicine.
ES2552506T3 (en) Nasal spray apparatus
AR080444A1 (en) METHODS FOR THE USE OF SODIUM-GLUCOSE TRANSPORTERS 1 AND 2
EA200802012A1 (en) PHARMACEUTICAL PREPARATIONS IN THE FORM OF SOLUTION FOR DOSING INHALERS UNDER PRESSURE
AR101593A2 (en) FORMOTEROL SUPERFINE FORMULATION
AR066074A1 (en) INJECTION DEVICE FOR DISPENSING A MEDICINAL PRODUCT
JP2011520911A5 (en)
CO6361944A2 (en) COMBINATION OF AN INSULIN AND A GLP-1 AGONIST
RS51107B (en) Dose display mechanism for a drug delivery device
ES2895875T3 (en) Aerosol delivery device and method of operation for the aerosol delivery device
BRPI0707235B8 (en) sublingual fentanyl formulation without propellant, and, unit dose device for sublingual administration of a sublingual fentanyl formulation
BRPI0508170A (en) pharmaceutical formulations for dry powder inhalers comprising a low dose potent active ingredient
AR095547A1 (en) NEBULIZER FOR BABIES AND PATIENTS WITH RESPIRATORY COMMITMENT
PE20091672A1 (en) NEW DOSAGE AND FORMULATION
JP2015523395A5 (en)
PE20080712A1 (en) TREATMENT OF CYYSTIC FIBROSIS WITH ANTIBIOTICS BY SUPPLYING A WHIRLPOOL
UY27398A1 (en) PROCEDURE FOR WELDING UNION THROUGH THE OWN MATERIAL OF CAPSULES FOR MEDICINAL USE BY INHALATION AND APPLIANCE TO PERFORM THE WELDING UNION.
CO5690570A2 (en) NEW SYNERGISTIC COMBINATION INCLUDING ROFLUMILAST AND FORMOTEROL
CO6140021A2 (en) PHARMACEUTICAL COMPOSITION OF MODIFIED RELEASE OF A RELAXING MUSCLE AND AN NSAID
AR099364A1 (en) MEDICATION INHALER
Stockmann et al. Clinical pharmacokinetics of inhaled antimicrobials

Legal Events

Date Code Title Description
FA Abandonment or withdrawal